What's new

Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Date of authorisation: 31/08/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Date of authorisation: 31/08/2018, Revision: 14, Status: Authorised

May 23, 2025 - 08:15
 0
Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Date of authorisation: 31/08/2018, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Date of authorisation: 31/08/2018, Revision: 14, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Revestive, teduglutide...

Next Article

Human medicines European public assessment report (EPAR): Abrysvo, Respiratory s...

Related Posts

Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 May 2025, 12:30 (CEST) to 22 May 2025, 17:30 (CEST)

Clinical Trials Information System (CTIS): Information ...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Records of data processing activity for the Organisatio...

May 19, 2025  0